xiyanping
Xiyanping (喜炎平) is an anti-inflammatory and antiviral preparation developed and licensed for use in China. It is a semi-synthetic injectable product derived from the active component of the plant Andrographis paniculata, which is used in Traditional Chinese medicine. Xiyanping is primarily composed of 9-dehydro-17-hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate. It is used mainly in the treatment of hand, foot and mouth disease, diarrhea, upper respiratory tract infections and viral pneumonia, though one case report suggested it may also be useful in the treatment of Zika fever. — Wikipedia
Clinical trial activity
11 trials · 16 clinical orgs · 0 marketing orgs
Earliest trial started May 1, 2010 (NCT01554930)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaXiyanping ↗
Also known as
- xiyanping
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07182942 | Phase 4 | Jun 7, 2024 | Huazhong University of Science and Technology |
| NCT04926506 | N/A | Oct 8, 2021 | Qingfeng Pharmaceutical Group |
| NCT04296383 | N/A | Mar 15, 2020 | Qingfeng Pharmaceutical Group |
| NCT04295551 | N/A | Mar 14, 2020 | Qingfeng Pharmaceutical Group |
| NCT04275388 | N/A | Feb 14, 2020 | Qingfeng Pharmaceutical Group |
| NCT03947411 | N/A | Mar 4, 2019 | Cangzhou People's Hospital, Capital Medical University, Liaoning Hospital of Traditional Chinese Medicine, Qingdao Municipal Hospital, Qingfeng Pharmaceutical Group, Tianjin University of Traditional Chinese Medicine |
| NCT02937857 | Phase 4 | Aug 1, 2016 | Qingfeng Pharmaceutical Group, Sichuan University |
| NCT02362906 | N/A | Apr 1, 2014 | Liaoning Hospital of Traditional Chinese Medicine, Peking University |
| NCT02069665 | N/A | Dec 1, 2011 | Liaoning Hospital of Traditional Chinese Medicine, Peking University |
| NCT01182025 | N/A | Jun 1, 2010 | An'Hui Chinese Medical College, Anhui Medical University, China Academy of Chinese Medical Sciences, Peking University |
| NCT01554930 | N/A | May 1, 2010 | Anhui College of Traditional Chinese Medicine, Capital Medical University, China Academy of Chinese Medical Sciences, Guangxi Medical University, Handan Maternal and Child Health Care Hospital, Jiangxi Children's Hospital, Peking University, Qingfeng Pharmaceutical Group |
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Qingfeng Pharmaceutical Group | For profit | 7 | 7 | 2 | 2010 |
| Peking University | Academic/Hospital | 4 | 0 | 1 | 2010 |
| Liaoning Hospital of Traditional Chinese Medicine | Academic/Hospital | 3 | 2 | 1 | 2011 |
| Capital Medical University | Academic/Hospital | 2 | 0 | 1 | 2010 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 2 | 0 | 1 | 2010 |
| An'Hui Chinese Medical College | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Anhui College of Traditional Chinese Medicine | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Anhui Medical University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Cangzhou People's Hospital | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Guangxi Medical University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Handan Maternal and Child Health Care Hospital | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Jiangxi Children's Hospital | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Qingdao Municipal Hospital | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Tianjin University of Traditional Chinese Medicine | Academic/Hospital | 1 | 0 | 1 | 2019 |